🔎 Trials Near Me

Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › New Jersey

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di New Jersey

26 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi di New Jersey.

Kota di New Jersey

Teks studi resmi (Bahasa Inggris)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

  • Jefferson Cherry Hill Hospital, Cherry Hill
  • Sidney Kimmel Cancer Center Washington Township, Sewell
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06992427

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Hackensack Meridian Health (Site # 119), Hackensack
  • Site #0145, Newark
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #88, East Brunswick
  • Exelixis Clinical Site #105, Hackensack
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06589804

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 12, Morristown
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, New Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05877599

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06385080

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

  • Hackensack University Medical Center, Hackensack
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06980038

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaFase 2
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04671667

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Astera Cancer Care, East Brunswick
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Jersey City Medical Center, Jersey City
  • Cooperman Barnabas Medical Center, Livingston
  • Monmouth Medical Center, Long Branch
  • dan 5 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

  • Site 104 - START New Jersey, East Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07462377

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Hackensack
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Saint Barnabas Medical Center, Livingston
  • Memorial Sloan Kettering Monmouth, Middletown
  • dan 2 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04333537

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • John Theurer Cancer Center, Hackensack
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04895709

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05544136

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05859074

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

  • Valley - Mount Sinai Comprehensive Cancer Care, Paramus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05419089

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT04722523

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

  • Hackensack University Medical Center, Hackensack
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06747585

A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT06485778

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT07063212

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Hackensack University Medical Center, Hackensack
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Englewood Hospital and Medical Center (site 202), Englewood
  • Summit Medical Group (site 205), Florham Park
  • Atlantic Health System, Morristown Medical Center (site 124), Morristown
Menerima pesertaFase 1/2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT03556228

RAPA-201 Therapy of Solid Tumors

  • Hackensack University Medical Center, Hackensack
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2025 · NCT05144698

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.